Pivmecillinam
Sponsors
Uppsala Universitet, Odense University Hospital, Inmunotek S.L., Sykehuset i Vestfold HF, Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Conditions
Antibiotic ProphylaxisBacteriuriaBladder Cancer Requiring CystectomyBloodstream InfectionComplicated urinary tract infections (cUTI) requiring hospitalisationCystectomyFebrile Urinary Tract InfectionIleal Conduit
Phase 2
Phase 3
Prediction and Prevention of Bloodstream Infections After Kidney Transplantation
Not yet recruitingNCT07407673
Start: 2027-01-01End: 2041-07-01Target: 180Updated: 2026-07-22
Multicentre, randomised, double-blind, placebo-controlled clinical trial to confirm the efficacy, safety, and clinical impact of the mucosal bacterial therapeutic vaccine MV140 in women with non-complicated recurrent urinary tract infections (rUTIs).
Not yet recruitingCTIS2025-524377-16-00
Target: 252Updated: 2026-05-19
Phase 4
Treating Pyelonephritis an Urosepsis With Pivmecillinam
CompletedNCT03282006
Start: 2017-09-29End: 2020-04-21Updated: 2020-04-22
Clinical Effectiveness and Bacteriological Eradication of 4 Short-course Antibiotics for Uncomplicated UTIs in Women.
CompletedNCT04959331
Start: 2021-11-02End: 2024-12-31Updated: 2025-09-08
Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis
RecruitingNCT06709196
Start: 2025-01-07End: 2027-01-31Target: 248Updated: 2025-01-09
Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of Care
RecruitingNCT07236944
Start: 2025-12-31End: 2029-03-31Target: 560Updated: 2025-12-17
Evidence based empirical antibiotic treatment for urinary tract infections requiring hospitalisation - TRI-AB trial
Not yet recruitingCTIS2024-520251-24-00
Target: 618Updated: 2026-03-27